| genital viral surveillance among sexually active adolescent girls. | | 1977 | 192871 |
| a multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients. | thirty-three consecutive liver-transplant recipients were prospectively studied over a 37-mo period for evidence of cytomegalovirus infection. sixteen (48%) episodes of cytomegalovirus infection were identified; 9 were primary infections and 7 were recurrent infections. beginning with patient 8, gamma-globulin prophylaxis was routinely administered to most patients. twelve potential risk factors for cytomegalovirus infection were evaluated and included pretransplant cytomegalovirus serological s ... | 1990 | 1691121 |
| multiple sclerosis in galion, ohio: prevalence and results of a case-control study. | an investigation of the occurrence of multiple sclerosis (ms) was undertaken in the city of galion, ohio, usa, because of a report of an increased number of cases. as of june 1, 1987, there were 18 living cases of ms in galion and polk township, for a prevalence rate of 112 cases per 100,000 population. the expected rate is approximately 65-170 cases per 100,000. in a case-control study, residents of galion or polk township who had ms were compared to residents who did not have ms. the controls ... | 1991 | 1745329 |
| inapparent congenital cytomegalovirus infection. clinical and epidemiologic characteristics in early infancy. | | 1970 | 4314607 |
| seroepidemiologic aspects of cytomegalovirus infection in a general hospital pediatric population: a pilot study. | | 1981 | 6266987 |
| cytomegalovirus antibody status and kidney transplantation. | 1. first cadaver-donor recipients had a 7% death rate if the kidney originated from a cmv+ donor compared with 5% if the kidney came from a cmv-donor. this 2% difference was highly significant (p < 0.001). graft survival rates were correspondingly 2-3% lower as a result of deaths. 2. this same trend was noted in the 1991-1993 period as in the 1988-1990 period. 3. increased incidence of deaths in d+/r+ transplants was most frequently statistically significant when patients were divided by early f ... | 1994 | 7547579 |
| stability of cytomegalovirus antibodies in plasma during prolonged storage of blood components. | cytomegalovirus (cmv) antibody testing is currently limited by manufacturers' guidelines to specimens stored for 7 days or less. we examined the stability of cmv antibodies in plasma from platelets and whole-blood units during storage using a rapid, automated, recombinant protein-based immunoassay which qualitatively detects total antibody to human cmv. testing of single-donor apheresis platelets was performed on baseline serum and platelet-free plasma and on platelet-free plasma 8 days later. i ... | 1995 | 7719908 |
| risk factors for death after heart transplantation: does a single-center experience correlate with multicenter registries? | risk factors for death after heart transplantation (tx) are frequently documented from multicenter registries. although this information is helpful, it reflects a whole range of experiences and results, and may not translate to a particular center. this study was performed to (1) evaluate pre-tx factors affecting mortality in a single-center experience, and (2) compare these factors with risk factors obtained from multicenter registry reports. | 1998 | 9647061 |
| a phase 1 study of 4 live, recombinant human cytomegalovirus towne/toledo chimeric vaccines. | human cytomegalovirus (hcmv) infection acquired in utero often results in severe consequences, including mental retardation and deafness. although not evaluated for this indication, live attenuated hcmv vaccines based on the towne strain are well-tolerated and have demonstrated moderate efficacy in other clinical settings. | 2006 | 16619181 |
| restless legs syndrome in lung transplant recipients. | given the increased incidence of steroid-induced diabetes and drug-induced anemia, renal dysfunction and neuropathy, we believed that lung transplant recipients would be at an increased risk of developing restless legs syndrome (rls). we performed a cross-sectional, observational study to determine the prevalence and characteristics of rls in this population. | 2007 | 17234513 |
| ocular complications in patients with lung transplants. | aim to describe infectious and non-infectious ocular complications found in patients with lung transplants. methods 545 patients underwent lung transplantation from january 1998 to september 2008 at the cleveland clinic. patients who underwent ophthalmic examination at the cole eye institute after lung transplantation were included in the study. outcomes diagnoses, treatments, surgeries, laboratory parameters of immune status and patient survival were examined. results of the 545 patients who re ... | 2010 | 21131376 |
| cost analysis of conventional facial reconstruction procedures followed by face transplantation. | for the first time, this study analyzes the cost of multiple conventional reconstructions and face transplantation in a single patient. this patient is a 46-year-old female victim of a shotgun blast resulting in loss of multiple functional and aesthetic subunits. for over 5 years, she underwent multiple conventional reconstructions with suboptimal results. in december 2008, she became the recipient of the first u.s. face transplant. this has provided the unique opportunity to present the cost of ... | 2011 | 21272241 |
| cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype. | objectives: cytomegalovirus reactivation is common after reduced-intensity conditioning allogeneic hematopoietic stem cell transplant. natural killer and t cells mediate immunity against viruses including cytomegalovirus. the alloreactivity of natural killer cells and some t-cell subsets is mediated through the interaction of their killer immunoglobulin-like receptors with target cell ligands. this study sought to assess whether donor inhibitory or activating killer immunoglobulin-like receptor ... | 2011 | 21605017 |